Reference:
1. WHO. Cardiovascular diseases (CVDs) . 2017; Available from: https://www.who.int/en/news-room/fact-sheets/detail/cardiovascular-diseases-(cvds).
2. Mechanic, O.J. and S.A. Grossman, Acute Myocardial Infarction . 2019, StatPearls Publishing.
3. Carville, S.F., R. Henderson, and H. Gray, The acute management of ST-segment-elevation myocardial infarction. Clinical medicine (London, England), 2015. 15 (4): p. 362-367.
4. Shi, W.Y. and J.A. Smith, Role of Coronary Artery Bypass Surgery in Acute Myocardial Infarction . 2018, Springer.
5. Raghavan, R., B.S. Benzaquen, and L. Rudski, Timing of bypass surgery in stable patients after acute myocardial infarction. The Canadian journal of cardiology, 2007. 23 (12): p. 976-982.
6. Werner, N., G. Nickenig, and J.-M. Sinning, Complex PCI procedures: challenges for the interventional cardiologist. 2018.107 (2): p. 64-73.
7. Caceres, M. and D.S. Weiman, Optimal timing of coronary artery bypass grafting in acute myocardial infarction. Ann Thorac Surg, 2013.95 (1): p. 365-72.
8. Goldfarb, M., et al., Outcome Reporting in Cardiac Surgery Trials: Systematic Review and Critical Appraisal. Journal of the American Heart Association, 2015. 4 (8): p. e002204-e002204.
9. Spadaccio, C. and U. Benedetto, Coronary artery bypass grafting (CABG) vs. percutaneous coronary intervention (PCI) in the treatment of multivessel coronary disease: quo vadis? -a review of the evidences on coronary artery disease. Annals of cardiothoracic surgery, 2018.7 (4): p. 506-515.
10. Bundhun, P.K., C.M. Yanamala, and F. Huang, Percutaneous Coronary Intervention, Coronary Artery Bypass Surgery and the SYNTAX score: A systematic review and meta-analysis. Scientific reports, 2017.7 : p. 43801-43801.
11. Baig, K., et al., Does coronary artery bypass grafting improve quality of life in elderly patients? Interactive cardiovascular and thoracic surgery, 2013. 17 (3): p. 542-553.
12. Stone, G.W., et al., Five-Year Outcomes after PCI or CABG for Left Main Coronary Disease. N Engl J Med, 2019. 381 (19): p. 1820-1830.
13. Chang, M., et al., Comparison of Outcome of Coronary Artery Bypass Grafting Versus Drug-Eluting Stent Implantation for Non–ST-Elevation Acute Coronary Syndrome. 2017. 120 (3): p. 380-386.
14. Ngaage, D.L., F. Sogliani, and A. Tang, Early and late prognostic implications of coronary artery bypass timing after myocardial infarction. European Journal of Cardio-Thoracic Surgery, 2012. 43 (3): p. 549-554.
15. Hachet, O., et al., Frequency and predictors of stroke after acute myocardial infarction: specific aspects of in-hospital and postdischarge events. Stroke, 2014. 45 (12): p. 3514-20.
16. Tamer Owais, A.F., Mohamed Adel, Martin Breuer, Jurgen Fuchs, Bernward Lauer, Thomas Kuntze, Timing and Outcome of Coronary Artery Bypass Grafting in STEMI: On-Pump and off-Pump Dilemma. Journal of Cardiology & Current Research, 2017.
17. Violette, P.D., et al., A cost analysis of nonelective coronary artery bypass graft surgery. J Card Surg, 2006.21 (6): p. 621-7.
18. Sun, L.Y., et al., Long-term Outcomes in Patients With Severely Reduced Left Ventricular Ejection Fraction Undergoing Percutaneous Coronary Intervention vs Coronary Artery Bypass Grafting.2020. 5 (6): p. 631-641.
19. Mølstad, P., R. Moer, and O. Rødevand, Long-term survival after coronary bypass surgery and percutaneous coronary intervention.Open Heart, 2016. 3 (2): p. e000489.
20. Nichols, E.L., et al., Optimal Timing From Myocardial Infarction to Coronary Artery Bypass Grafting on Hospital Mortality.Ann Thorac Surg, 2017. 103 (1): p. 162-171.
21. Gu, Y.L., et al., Role of coronary artery bypass grafting during the acute and subacute phase of ST-elevation myocardial infarction. Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation, 2010. 18 (7-8): p. 348-354.
22. Grothusen, C., et al., Outcome of Stable Patients With Acute Myocardial Infarction and Coronary Artery Bypass Surgery Within 48 Hours: A Single-Center, Retrospective Experience. Journal of the American Heart Association, 2017. 6 (10): p. e005498.
23. Davierwala Piroze, M., et al., Does Timing of Coronary Artery Bypass Surgery Affect Early and Long-Term Outcomes in Patients With Non–ST-Segment–Elevation Myocardial Infarction? Circulation, 2015.132 (8): p. 731-740.
24. Parikh, S.V., et al., Timing of in-hospital coronary artery bypass graft surgery for non-ST-segment elevation myocardial infarction patients results from the National Cardiovascular Data Registry ACTION Registry-GWTG (Acute Coronary Treatment and Intervention Outcomes Network Registry-Get With The Guidelines) , in JACC Cardiovasc Interv . 2010, 2010 American College of Cardiology Foundation. Published by Elsevier Inc: United States. p. 419-27.
25. Ha, L.D., et al., Early versus delayed coronary artery bypass graft surgery for patients with non-ST elevation myocardial infarction.Coron Artery Dis, 2017. 28 (8): p. 670-674.
26. Assmann, A., et al., Appropriate timing of coronary artery bypass grafting after acute myocardial infarction. Thorac Cardiovasc Surg, 2012. 60 (7): p. 446-51.
27. Wu, C., et al., Risk Score for Predicting Long-Term Mortality After Coronary Artery Bypass Graft Surgery. Circulation, 2012.125 (20): p. 2423-2430.
28. Farkouh, M.E., et al., Strategies for Multivessel Revascularization in Patients with Diabetes. New England Journal of Medicine, 2012. 367 (25): p. 2375-2384.
29. Kapur, A., et al., The Coronary Artery Revascularisation in Diabetes (CARDia) trial: background, aims, and design. Am Heart J, 2005. 149 (1): p. 13-9.
30. Group, B.D.S., A Randomized Trial of Therapies for Type 2 Diabetes and Coronary Artery Disease. New England Journal of Medicine, 2009. 360 (24): p. 2503-2515.
31. Abdallah, M.S., et al., Quality of life after PCI vs CABG among patients with diabetes and multivessel coronary artery disease: a randomized clinical trial. Jama, 2013. 310 (15): p. 1581-90.
32. NICE, Unstable Angina and NSTEMI: the early management of unstable angina and non-ST-segment-elevation myocardial infarction. Clinical guideline 94 . 2013. p. 31, 169.
33. Cardiology, E.S.o., Guidelines on myocardial revascularization . 2018.
34. NICE, Myocardial infarction with ST-segment elevation: the acute management of myocardial infarction withST-segment elevation. Clinical guideline 167 . 2013.
35. Hillis, L.D., et al., 2011 ACCF/AHA Guideline for Coronary Artery Bypass Graft Surgery. A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Developed in collaboration with the American Association for Thoracic Surgery, Society of Cardiovascular Anesthesiologists, and Society of Thoracic Surgeons. J Am Coll Cardiol, 2011. 58 (24): p. e123-210.
36. Hu, D., et al., Acute Coronary Syndrome Risk Prediction Based on GRACE Risk Score. Stud Health Technol Inform, 2017. 245 : p. 398-402.
37. society, B.c., Myocardial Ischaemia National Audit Project (MINAP) . 2019.
38. Gale, C.P., et al., Resolving inequalities in care? Reduced mortality in the elderly after acute coronary syndromes. The Myocardial Ischaemia National Audit Project 2003-2010. Eur Heart J, 2012.33 (5): p. 630-9.
39. Toleva, O., et al., Practice patterns and clinical outcomes among non-ST-segment elevation acute coronary syndrome (NSTE-ACS) patients presenting to primary and tertiary hospitals: insights from the EARLY glycoprotein IIb/IIIa inhibition in NSTE-ACS (EARLY-ACS) trial.Catheter Cardiovasc Interv, 2014. 84 (6): p. 934-42.
40. Hall, M., et al., Association of Clinical Factors and Therapeutic Strategies With Improvements in Survival Following Non-ST-Elevation Myocardial Infarction, 2003-2013. JAMA, 2016.316 (10): p. 1073-82.
41. Lee, D.C., et al., Appropriate timing of surgical intervention after transmural acute myocardial infarction. J Thorac Cardiovasc Surg, 2003. 125 (1): p. 115-9; discussion 119-20.
42. Weiss, E.S., et al., Optimal timing of coronary artery bypass after acute myocardial infarction: a review of California discharge data. J Thorac Cardiovasc Surg, 2008. 135 (3): p. 503-11, 511.e1-3.
43. Mehta, S.R., et al., Early versus delayed invasive intervention in acute coronary syndromes. N Engl J Med, 2009.360 (21): p. 2165-75.
44. Milasinovic, D., et al., Three-Year Impact of Immediate Invasive Strategy in Patients With Non-ST-Segment Elevation Myocardial Infarction (from the RIDDLE-NSTEMI Study). Am J Cardiol, 2018.122 (1): p. 54-60.
45. Montalescot, G., et al., Effect of prasugrel pre-treatment strategy in patients undergoing percutaneous coronary intervention for NSTEMI: the ACCOAST-PCI study. J Am Coll Cardiol, 2014.64 (24): p. 2563-2571.
46. Farkouh, M.E., et al., Impact of Chronic Kidney Disease on Outcomes of Myocardial Revascularization in Patients With Diabetes. J Am Coll Cardiol, 2019. 73 (4): p. 400-411.
47. Najafi, M., M. Sheikhvatan, and S.H. Mortazavi, Do preoperative pulmonary function indices predict morbidity after coronary artery bypass surgery? Annals of cardiac anaesthesia, 2015.18 (3): p. 293-298.
48. Kosmidou, I., et al., C-reactive protein and prognosis after percutaneous coronary intervention and bypass graft surgery for left main coronary artery disease: Analysis from the EXCEL trial. Am Heart J, 2019. 210 : p. 49-57.
49. Thielmann, M., et al., Predictors and outcomes of coronary artery bypass grafting in ST elevation myocardial infarction. Ann Thorac Surg, 2007. 84 (1): p. 17-24.
50. Ng, V.G., et al., The prognostic importance of left ventricular function in patients with ST-segment elevation myocardial infarction: the HORIZONS-AMI trial. European heart journal. Acute cardiovascular care, 2014. 3 (1): p. 67-77.
51. Yang, T., et al., Myocardial scar identified by magnetic resonance imaging can predict left ventricular functional improvement after coronary artery bypass grafting. PloS one, 2013. 8 (12): p. e81991-e81991.
52. Sheriff, M.J., et al., Cardiac Magnetic Resonance Imaging Predictors of Short-Term Outcomes after High Risk Coronary Surgery.2016. 25 (6): p. 613-619.
53. Nucifora, G. and J.B. Selvanayagam, Cardiac Magnetic Resonance Imaging Before Coronary Artery Bypass Graft Surgery: Is It Ready for Risk Stratification? 2016. 25 (6): p. 535-537.
54. Hausenloy, D.J., et al., The effect of cyclosporin-A on peri-operative myocardial injury in adult patients undergoing coronary artery bypass graft surgery: a randomised controlled clinical trial.Heart, 2014. 100 (7): p. 544.